Sarah Kenny

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Tim Maughan, Richard Adams, Christopher G. Smith et al. · The Lancet · 2011 · 964 citations

Gastrointestinal Oncology, Medicine, Randomised Phase 3 +8

2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie et al. · Arthritis & Rheumatology · 2018 · 465 citations · Full text

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Richard Adams, Angela Meade, Richard H. Wilson et al. · The Lancet Oncology · 2011 · 262 citations · Full text

Mesonephric Adenocarcinomas of the Uterine Cervix and Corpus

Sarah Kenny, Hilary A. McBride, Jackie Jamison et al. · The American Journal of Surgical Pathology · 2012 · 168 citations

Precancerous Lesions, Immunology, Pathology +16

Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: ALTERNATIVE

Stephen Johnston, Roberto Hegg, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2017 · 166 citations · Full text